Hookah Smoke Increases Benzene Levels, Is No Safer than Tobacco Smoking
the Cancer Therapy Advisor take:
It is commonly believed that hookah smoke is a far safer version of smoke because of the way in which hookah is filtered (ie, through water before inhalation).
However, according to research recently publishing in the journal of the American Association for Cancer Research, Cancer Epidemiology, Biomarkers, and Prevention, people who smoke hookah and people who are exposed to hookah smoke (such as individuals who are around hookah smokers at lounges and social events) had a signficiantly increased amount of benzene, which is a chemical substance that is associated with leukemia risk.
Nada Kassem, associate director of the Center for Behavioral Epidemiology and Community Health at San Diego State University, was the lead researcher of the study and stated that this study is clear evidence that the belief that hookah smoke is not harmful is simply untrue.
In their research Kassem et al analyzed the urine of 105 hookah smokers and 103 nonsmokers to seek the levels of S-phenylmercapturic acid (SPMA), a metabolite on benzene. Researchers found that the level of SPMA was elevated by four times in hookah smokers and two times by nonsmokers who attended an event in a hookah lounge.
Nassem and colleagues state that their research reveals that hookah smoke is no safer than any other form of tobacco smoking and regulations should take this into account.
People who smoke hookah had a signficiantly increased amount of benzene and leukemia risk.
Some people believe that because hookah smoke is filtered through water before being inhaled, it's somehow safer than smoking cigarettes or other forms of tobacco. But that's simply not the case, according to Nada Kassem, associate director at the Center for Behavioral Epidemiology and Community Health at San Diego State University.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Real-World Study Shows High Response Rates to T-VEC in Early Metastatic Melanoma
- Are Next-Gen Antibody-Drug Conjugates a Path Forward for Non-Hodgkin Lymphoma and Myeloma?
- Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection
- Ponatinib Tops Bosutinib for Third-Line Treatment of CML in a Comparative Analysis
- Plastics and Cancer
- FDA-Approved Breast Cancer Drug Treatments
- A Trained Dog Smells Early-Stage Lung Cancer With a High Degree of Accuracy
- FDA-Approved Colorectal Cancer Drug Treatments
- Synthetic or Plant-Based Cannabis for Symptom Relief in Patients With Cancer: Do We Have Any Evidence?
- Emetogenic Potential of Antineoplastic Agents
- 20-Year Data Link High-Dose Chemotherapy and Hematopoietic Stem Cell Transplant to Survival Benefit in High-Risk Early Breast Cancer
- Cabozantinib Shows Promising Activity in Osteosarcoma and Ewing Sarcoma
- Reducing Trastuzumab Duration Lowers Costs by Nearly £10,000 in HER2-positive Breast Cancer
- Resistance Mechanisms Identified for NSCLC Progression With First-Line Osimertinib
- Atezolizumab and Nab-Paclitaxel Prolonged PFS in Metastatic Triple-Negative Breast Cancer